A number of other equities research analysts have also issued reports on the stock. KeyCorp upped their target price on shares of ATI from $33.00 to $36.00 and gave the stock an overweight rating in a report on Monday, December 5th. StockNews.com raised shares of ATI from a sell rating to a hold rating in a report on Monday, October 24th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, ATI presently has a consensus rating of Moderate Buy and an average target price of $33.20.
ATI Stock Up 0.1 %
Shares of ATI stock opened at $35.56 on Friday. The company has a market cap of $4.60 billion, a P/E ratio of 323.30 and a beta of 1.21. ATI has a 52-week low of $17.71 and a 52-week high of $36.25. The company has a quick ratio of 1.40, a current ratio of 2.88 and a debt-to-equity ratio of 1.81. The firm’s 50 day moving average price is $31.05 and its 200-day moving average price is $29.41.
Insider Activity at ATI
In other ATI news, CEO Robert S. Wetherbee sold 15,000 shares of the company’s stock in a transaction dated Tuesday, November 1st. The shares were sold at an average price of $30.23, for a total value of $453,450.00. Following the transaction, the chief executive officer now owns 333,753 shares of the company’s stock, valued at $10,089,353.19. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, insider Elliot S. Davis sold 28,572 shares of the stock in a transaction dated Tuesday, December 6th. The shares were sold at an average price of $30.68, for a total transaction of $876,588.96. Following the sale, the insider now owns 160,350 shares of the company’s stock, valued at $4,919,538. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Robert S. Wetherbee sold 15,000 shares of the stock in a transaction dated Tuesday, November 1st. The stock was sold at an average price of $30.23, for a total transaction of $453,450.00. Following the sale, the chief executive officer now directly owns 333,753 shares in the company, valued at approximately $10,089,353.19. The disclosure for this sale can be found here. 0.82% of the stock is currently owned by insiders.
Institutional Trading of ATI
Hedge funds have recently added to or reduced their stakes in the company. Gamble Jones Investment Counsel purchased a new position in ATI in the third quarter valued at approximately $84,000. Convergence Investment Partners LLC purchased a new position in ATI in the third quarter valued at approximately $103,000. Canada Pension Plan Investment Board purchased a new position in ATI in the third quarter valued at approximately $114,000. Quadrant Capital Group LLC increased its stake in ATI by 1,116.5% in the third quarter. Quadrant Capital Group LLC now owns 4,416 shares of the basic materials company’s stock valued at $118,000 after purchasing an additional 4,053 shares during the last quarter. Finally, Captrust Financial Advisors increased its stake in ATI by 185.5% in the first quarter. Captrust Financial Advisors now owns 5,962 shares of the basic materials company’s stock valued at $160,000 after purchasing an additional 3,874 shares during the last quarter.
ATI Company Profile
ATI Inc manufactures and sells specialty materials and components worldwide. The company operates in two segments: High Performance Materials & Components (HPMC) and Advanced Alloys & Solutions (AA&S). The HPMC segment produces various materials, including titanium and titanium-based alloys, nickel- and cobalt-based alloys and superalloys, advanced powder alloys and other specialty materials, in long product forms, such as ingot, billet, bar, rod, wire, shapes and rectangles, and seamless tubes, as well as precision forgings, components, and machined parts.
- Get a free copy of the StockNews.com research report on ATI (ATI)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- When Will Crane Holdings Take Flight?
Receive News & Ratings for ATI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ATI and related companies with MarketBeat.com's FREE daily email newsletter.